TMDX

TransMedics Group, Inc.

75.78 USD
+2.56 (+3.50%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

TransMedics Group, Inc. stock is up 88.55% since 30 days ago. The next earnings date is Feb 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 4 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 34% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
14 Nov 20:18 17 Nov, 2023 45.00 CALL 20 308
16 Nov 17:45 19 Jan, 2024 65.00 CALL 50 138
17 Nov 17:13 15 Dec, 2023 70.00 CALL 100 350
21 Nov 15:59 15 Dec, 2023 70.00 CALL 81 469
21 Nov 16:01 19 Apr, 2024 50.00 PUT 90 11
21 Nov 16:01 19 Apr, 2024 95.00 CALL 90 6
27 Nov 18:58 20 Dec, 2024 90.00 PUT 11 1
29 Nov 20:17 19 Jan, 2024 40.00 CALL 20 37
01 Dec 17:49 19 Jan, 2024 45.00 CALL 10 14
04 Dec 14:48 19 Jan, 2024 80.00 CALL 62 89

About TransMedics Group, Inc.

TransMedics Group, Inc. engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system. OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation.

  • Morgan Stanley
    Mon Dec 4, 13:19
    hold
    confirm
  • JP Morgan
    Tue Nov 7, 15:07
    buy
    confirm
  • Morgan Stanley
    Tue Nov 7, 09:06
    hold
    confirm